Cargando…

Development of an orally bioavailable selective inhibitor of the menin-MLL

Detalles Bibliográficos
Autores principales:	Zhong, Hai-Jing, Wang, Wanhe, Zhou, Wei, Liang, Jia-Xin, Cheng, Yung-Chi, Ma, Dik-Lung, Leung, Chung-Hang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Chongqing Medical University 2022
Materias:	Rapid Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10363616/ https://www.ncbi.nlm.nih.gov/pubmed/37492738 http://dx.doi.org/10.1016/j.gendis.2022.10.005

Ejemplares similares

Development of a dual targeting scaffold of SET7/MLL inhibitor for castration-resistant prostate cancer treatment
por: Li, Guodong, et al.
Publicado: (2023)

Characterization of the Menin-MLL Interaction as Therapeutic Cancer Target
por: Brzezinka, Krzysztof, et al.
Publicado: (2020)

A Molecular Switch between Mammalian MLL Complexes Dictates Response to Menin–MLL Inhibition
por: Soto-Feliciano, Yadira M., et al.
Publicado: (2023)

Menin–MLL1 Interaction Small Molecule Inhibitors: A Potential Therapeutic Strategy for Leukemia and Cancers
por: Shi, Qing, et al.
Publicado: (2023)

Tumorigenicity of Ewing sarcoma is critically dependent on the trithorax proteins MLL1 and menin
por: Svoboda, Laurie K., et al.
Publicado: (2016)

The MLL–Menin Interaction is a Therapeutic Vulnerability in NUP98-rearranged AML
por: Rasouli, Milad, et al.
Publicado: (2023)

A novel Menin-MLL1 inhibitor, DS-1594a, prevents the progression of acute leukemia with rearranged MLL1 or mutated NPM1
por: Numata, Masashi, et al.
Publicado: (2023)

A long-lived peptide-conjugated iridium(iii) complex as a luminescent probe and inhibitor of the cell migration mediator, formyl peptide receptor 2
por: Vellaisamy, Kasipandi, et al.
Publicado: (2018)

The design and development of covalent protein-protein interaction inhibitors for cancer treatment
por: Cheng, Sha-Sha, et al.
Publicado: (2020)

The menin-MLL1 interaction is a molecular dependency in NUP98-rearranged AML
por: Heikamp, Emily B., et al.
Publicado: (2022)

Correction to: The design and development of covalent protein-protein interaction inhibitors for cancer treatment
por: Cheng, Sha-Sha, et al.
Publicado: (2020)

Multi-omics analyses of MEN1 missense mutations identify disruption of menin–MLL and menin–JunD interactions as critical requirements for molecular pathogenicity
por: Dreijerink, Koen M. A., et al.
Publicado: (2022)

Effective Menin inhibitor-based combinations against AML with MLL rearrangement or NPM1 mutation (NPM1c)
por: Fiskus, Warren, et al.
Publicado: (2022)

Discovery of a tetrahydroisoquinoline-based CDK9-cyclin T1 protein–protein interaction inhibitor as an anti-proliferative and anti-migration agent against triple-negative breast cancer cells
por: Cheng, Shasha, et al.
Publicado: (2021)

LBODP106 Multi-omics Analyses Of MEN1 Missense Mutations Identify Disruption Of Menin-MLL And Menin-JunD Interactions As Critical Requirements For Molecular Pathogenicity
por: Dreijerink, Koen Marie Anton, et al.
Publicado: (2022)

IKAROS and MENIN Coordinate Therapeutically Actionable Leukaemogenic Gene Expression in MLL-r Acute Myeloid Leukaemia
por: Aubrey, Brandon J., et al.
Publicado: (2022)

Dehydroeburicoic Acid, a Dual Inhibitor against Oxidative Stress in Alcoholic Liver Disease
por: Cheng, Shasha, et al.
Publicado: (2022)

Recent Progress and Development of G-Quadruplex-Based Luminescent Assays for Ochratoxin A Detection
por: Nao, Sang-Cuo, et al.
Publicado: (2020)

Activity of menin inhibitor ziftomenib (KO-539) as monotherapy or in combinations against AML cells with MLL1 rearrangement or mutant NPM1
por: Fiskus, Warren, et al.
Publicado: (2022)

Targeting of epigenetic co-dependencies enhances anti-AML efficacy of Menin inhibitor in AML with MLL1-r or mutant NPM1
por: Fiskus, Warren, et al.
Publicado: (2023)

Luminescent chemosensors by using cyclometalated iridium(iii) complexes and their applications
por: Ma, Dik-Lung, et al.
Publicado: (2017)

Co-inhibition of HDAC and MLL-menin interaction targets MLL-rearranged acute myeloid leukemia cells via disruption of DNA damage checkpoint and DNA repair
por: Ye, Jing, et al.
Publicado: (2019)

High-Affinity Small-Molecule Inhibitors of the Menin-Mixed Lineage Leukemia (MLL) Interaction Closely Mimic a Natural Protein–Protein Interaction
por: He, Shihan, et al.
Publicado: (2014)

Anticancer osmium complex inhibitors of the HIF-1α and p300 protein-protein interaction
por: Yang, Chao, et al.
Publicado: (2017)

Structure-Based Discovery of a Selective KDM5A Inhibitor that Exhibits Anti-Cancer Activity via Inducing Cell Cycle Arrest and Senescence in Breast Cancer Cell Lines
por: Yang, Guan-Jun, et al.
Publicado: (2019)

Structure-guided discovery of a luminescent theranostic toolkit for living cancer cells and the imaging behavior effect
por: Wu, Chun, et al.
Publicado: (2020)

Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism
por: Chou, Chih-Wei, et al.
Publicado: (2020)

Development of a luminescent G-quadruplex-selective iridium(III) complex for the label-free detection of adenosine
por: Lu, Lihua, et al.
Publicado: (2016)

Interference reduction isothermal nucleic acid amplification strategy for COVID-19 variant detection
por: Li, Guodong, et al.
Publicado: (2023)

Luminescent Iridium(III) Chemosensor for Tandem Detection of F(–) and Al(3+)
por: Liu, Jin-Biao, et al.
Publicado: (2017)

Menin inhibitor ziftomenib (KO-539) synergizes with drugs targeting chromatin regulation or apoptosis and sensitizes acute myeloid leukemia with MLL rearrangement or NPM1 mutation to venetoclax
por: Rausch, Johanna, et al.
Publicado: (2023)

A Metal-Based Inhibitor of NEDD8-Activating Enzyme
por: Zhong, Hai-Jing, et al.
Publicado: (2012)

Metal complexes as potential modulators of inflammatory and autoimmune responses
por: Leung, Chung-Hang, et al.
Publicado: (2015)

The role of menin in bone pathology
por: Gorbacheva, Anna, et al.
Publicado: (2022)

A bioactive ligand-conjugated iridium(III) metal-based complex as a Keap1–Nrf2 protein-protein interaction inhibitor against acetaminophen-induced acute liver injury
por: Li, Guodong, et al.
Publicado: (2021)

An Ir(III) complex chemosensor for the detection of thiols
por: Mao, Zhifeng, et al.
Publicado: (2016)

A label-free G-quadruplex-based mercury detection assay employing the exonuclease III-mediated cleavage of T–Hg(2+)–T mismatched DNA
por: Wang, Wanhe, et al.
Publicado: (2015)

Mimicking Strategy for Protein–Protein Interaction Inhibitor Discovery by Virtual Screening
por: Wu, Ke-Jia, et al.
Publicado: (2019)

Antagonizing STAT5B dimerization with an osmium complex
por: Liu, Li-Juan, et al.
Publicado: (2016)

FBP1 Is an Interacting Partner of Menin
por: Zaman, Shadia, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_ev0m1adlemg950u9slttpm3v6k